Next Article in Journal
Lung Cancer: Targeted Therapy in 2025
Previous Article in Journal
Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced Melanoma
 
 
Article

Article Versions Notes

Curr. Oncol. 2025, 32(3), 145; https://doi.org/10.3390/curroncol32030145
Action Date Notes Link
article xml file uploaded 2 March 2025 09:00 CET Original file -
article xml uploaded. 2 March 2025 09:00 CET Update -
article pdf uploaded. 2 March 2025 09:00 CET Version of Record -
article html file updated 2 March 2025 09:02 CET Original file -
article xml file uploaded 2 March 2025 10:56 CET Update -
article xml uploaded. 2 March 2025 10:56 CET Update https://www.mdpi.com/1718-7729/32/3/145/xml
article pdf uploaded. 2 March 2025 10:56 CET Updated version of record https://www.mdpi.com/1718-7729/32/3/145/pdf
article html file updated 2 March 2025 10:58 CET Update https://www.mdpi.com/1718-7729/32/3/145/html
Back to TopTop